Kiniksa Pharmaceuticals International Plc (KNSA)
95.76
+0.74
(+0.78%)
USD |
NASDAQ |
Nov 11, 16:00
95.83
+0.07
(+0.07%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.5575 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5575 |
| June 30, 2026 | 0.305 |
| March 31, 2026 | 0.2741 |
| December 31, 2025 | 0.1741 |
| September 30, 2025 | 0.2303 |
| June 30, 2025 | 0.2288 |
| March 31, 2025 | 0.1121 |
| December 31, 2024 | -0.1229 |
| September 30, 2024 | -0.177 |
| June 30, 2024 | -0.055 |
| March 31, 2024 | -0.2506 |
| December 31, 2023 | 0.3473 |
| September 30, 2023 | -0.1974 |
| June 30, 2023 | 0.209 |
| March 31, 2023 | -0.1759 |
| December 31, 2022 | 0.0625 |
| September 30, 2022 | 3.176 |
| June 30, 2022 | -0.2884 |
| March 31, 2022 | -0.3646 |
| December 31, 2021 | -0.5268 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.4448 |
| June 30, 2021 | -0.6077 |
| March 31, 2021 | -0.7248 |
| December 31, 2020 | -0.7884 |
| September 30, 2020 | -0.6646 |
| June 30, 2020 | -0.647 |
| March 31, 2020 | -0.4775 |
| December 31, 2019 | -0.5793 |
| September 30, 2019 | -0.4935 |
| June 30, 2019 | -0.6827 |
| March 31, 2019 | -1.272 |
| December 31, 2018 | -0.8604 |
| September 30, 2018 | -0.4934 |
| June 30, 2018 | -0.4097 |
| March 31, 2018 | -0.3232 |
| December 31, 2017 | -0.6613 |
| September 30, 2017 | -0.3242 |
| June 30, 2017 | -0.2266 |
| March 31, 2017 | -0.0999 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 47.34M |
| Revenue (Quarterly) | 285.97M |
| Total Expenses (Quarterly) | 238.62M |
| Enterprise Value | 6.955B |
| Gross Profit Margin (Quarterly) | 53.22% |
| Profit Margin (Quarterly) | 16.56% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 1.64% |
| Normalized Earnings Yield | 1.369 |